MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis

Open Access

Peer-reviewed

Research Article

Emily A. Kendall ,

* E-mail: ekendal2@jhmi.edu

Affiliation Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

http://orcid.org/0000-0002-0083-422X

⨯
Andrew S. Azman,

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯
Frank G. Cobelens,

Affiliation Amsterdam Institute for Global Health and Development, Academic Medical Centre, Amsterdam, Netherlands
⨯
David W. Dowdy

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯

Reader Comments (0)

Multi-drug-resistant tuberculosis
Is the Subject Area "Multi-drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Tuberculosis diagnosis and management
Is the Subject Area "Tuberculosis diagnosis and management" applicable to this article?

Thanks for your feedback.
Extensively drug-resistant tuberculosis
Is the Subject Area "Extensively drug-resistant tuberculosis" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.